[Reduction of coronary events: what are the possible mechanisms?]

Clinical studies have shown that lipid-lowering therapy reduces the incidence of cardiovascular events. However, lesion regression is relatively minor and does not seem to reflect the clear improvement in clinical events. Normalization of the lipid profile correlates with a reduction in atheromatous plaque complications. The responsible mechanisms for such reduction are diverse and are the subject of extensive research.